Centessa Pharmaceuticals plc American Depositary Shares (CNTA) is a publicly traded Healthcare sector company. As of May 20, 2026, CNTA trades at $39.55 with a market cap of $6.13B and a P/E ratio of -27.22. CNTA moved +0.18% today. Year to date, CNTA is +72.68%; over the trailing twelve months it is +201.14%. Its 52-week range spans $9.60 to $40.26. Analyst consensus is neutral with an average price target of $42.40. Rallies surfaces CNTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CNTA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CNTA recently traded at $39.55. Market cap is $6.13B. P/E ratio is -27.22. Revenue is $15.00M.
| Metric | Value |
|---|---|
| Price | $39.55 |
| Market Cap | $6.13B |
| P/E Ratio | -27.22 |
| EPS | $-1.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.26 |
| 52-Week Low | $9.60 |
| Volume | 814.63K |
| Avg Volume | 0 |
| Revenue (TTM) | $15.00M |
| Net Income | $-197.53M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $15.00M | $-197.53M | $-1.46 |
| 2024 | $0 | $-235.76M | $-2.06 |
| 2023 | $6.85M | $-151.09M | $-1.57 |
| 2022 | $0 | $-216.21M | $-2.31 |
10 analysts cover CNTA: 0 strong buy, 1 buy, 9 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $42.40.